Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Net Cash Flow (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Net Cash Flow of $36.2 million for Q1 2026, up 931.81% year-over-year from $3.5 million in Q1 2025, and up 211.12% quarter-over-quarter from $11.6 million in Q4 2025.

Analysis

Shattuck Labs (STTK) Net Cash Flow (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Net Cash Flow for 8 consecutive years, with $36.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Cash Flow rose 931.81% year-over-year to $36.2 million; the TTM figure through Mar 2026 stood at $29.5 million (up 295.41% YoY), while the FY2025 annual figure was -$3.2 million, up 95.32% from the prior year.
  • Net Cash Flow rose to $36.2 million in Q1 2026 per STTK's latest filing, from $11.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $85.0 million in Q4 2023 and bottomed at -$49.6 million in Q1 2024.
  • Historically, Net Cash Flow has averaged -$108764.7 across 5 years, with a median of $1.9 million in 2022.
  • On a YoY basis, Net Cash Flow climbed as much as 1015.26% in 2023 and fell as far as 1755.77% in 2023.
  • Shattuck Labs' Net Cash Flow stood at $7.6 million in 2022, then jumped by 1015.26% to $85.0 million in 2023, then tumbled by 84.05% to $13.6 million in 2024, then slipped by 14.12% to $11.6 million in 2025, then surged by 211.12% to $36.2 million in 2026.
  • Business Quant data shows STTK's Net Cash Flow at $36.2 million in Q1 2026, $11.6 million in Q4 2025, and -$7.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn - -27.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.12 Mn
Mar 31, 2026 36.23 Mn
Dec 31, 2025 11.64 Mn
Sep 30, 2025 -7.92 Mn
Jun 30, 2025 -10.43 Mn
Mar 31, 2025 3.51 Mn
Dec 31, 2024 13.56 Mn
Sep 30, 2024 -16.86 Mn
Jun 30, 2024 -15.31 Mn
Mar 31, 2024 -49.62 Mn
Dec 31, 2023 84.99 Mn
Sep 30, 2023 -31.26 Mn
Jun 30, 2023 5.85 Mn
Mar 31, 2023 18.66 Mn
Dec 31, 2022 7.62 Mn
Sep 30, 2022 1.89 Mn
Jun 30, 2022 -12.87 Mn
Mar 31, 2022 -41.53 Mn
Dec 31, 2021 7.17 Mn
Sep 30, 2021 -1.40 Mn